Literature DB >> 2787244

The globular domains of type VI collagen are related to the collagen-binding domains of cartilage matrix protein and von Willebrand factor.

E Koller1, K H Winterhalter, B Trueb.   

Abstract

Type VI collagen is a transformation-sensitive glycoprotein of the extracellular matrix of fibroblasts. We have isolated and sequenced several overlapping cDNA clones (4153 bp) which encode the entire alpha 2 subunit of chicken type VI collagen. The deduced amino acid sequence predicts that the alpha 2(VI) polypeptide consists of 1015 amino acid residues that are arranged in four domains: a hydrophobic signal peptide of 20 residues, an amino-terminal globular domain of 228 residues, a collagenous segment of 335 residues and a carboxy-terminal globular domain of 432 residues. The collagenous domain contains seven Arg-Gly-Asp tripeptide units, some of which are likely to be used as cell-binding sites. The globular domains contain three homologous repeats with an average length of 180 amino acid residues. These repeats show a striking similarity to the collagen-binding motifs found in von Willebrand factor and cartilage matrix protein. We therefore speculate that the globular domains of the alpha 2(VI) polypeptide may interact with collagenous structures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787244      PMCID: PMC400916          DOI: 10.1002/j.1460-2075.1989.tb03475.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  21 in total

Review 1.  Human von Willebrand factor: the molecular glue of platelet plugs.

Authors:  K Titani; K A Walsh
Journal:  Trends Biochem Sci       Date:  1988-03       Impact factor: 13.807

2.  CL glycoprotein is the tissue form of type VI collagen.

Authors:  M A Gibson; E G Cleary
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

3.  Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.

Authors:  R Pytela; M D Pierschbacher; M H Ginsberg; E F Plow; E Ruoslahti
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

4.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Electron-microscopical approach to a structural model of intima collagen.

Authors:  H Furthmayr; H Wiedemann; R Timpl; E Odermatt; J Engel
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

8.  Transformation-dependent alterations is glycoproteins of extracellular matrix of human fibroblasts. Characterization of GP250 and the collagen-like GP140.

Authors:  W G Carter
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

9.  Type VI collagen in extracellular, 100-nm periodic filaments and fibrils: identification by immunoelectron microscopy.

Authors:  R R Bruns; W Press; E Engvall; R Timpl; J Gross
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

10.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.

Authors:  L Y Sakai; D R Keene; E Engvall
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  13 in total

1.  Molecular composition of type VI collagen. Evidence for chain heterogeneity in mammalian tissues and cultured cells.

Authors:  C M Kielty; R P Boot-Handford; S Ayad; C A Shuttleworth; M E Grant
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  More von Willebrand factor type A domains? Sequence similarities with malaria thrombospondin-related anonymous protein, dihydropyridine-sensitive calcium channel and inter-alpha-trypsin inhibitor.

Authors:  P Bork; K Rohde
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

3.  Type III collagen in the intervertebral disc.

Authors:  S Roberts; J Menage; V Duance; S F Wotton
Journal:  Histochem J       Date:  1991 Nov-Dec

4.  Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface.

Authors:  A Nishiyama; W B Stallcup
Journal:  Mol Biol Cell       Date:  1993-11       Impact factor: 4.138

5.  150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.

Authors:  J H Rand; N D Patel; E Schwartz; S L Zhou; B J Potter
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  Cloning of alpha 2 chain of type VI collagen and expression during mouse development.

Authors:  A Ibrahimi; B Bertrand; S Bardon; E Z Amri; P Grimaldi; G Ailhaud; C Dani
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

7.  The promoter of the chicken alpha 2(VI) collagen gene has features characteristic of house-keeping genes and of proto-oncogenes.

Authors:  E Koller; A R Hayman; B Trueb
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

8.  Cloning and sequence analysis of cDNAs encoding the alpha 1, alpha 2 and alpha 3 chains of mouse collagen VI.

Authors:  R Z Zhang; T C Pan; R Timpl; M L Chu
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors.

Authors:  M L Chu; R Z Zhang; T C Pan; D Stokes; D Conway; H J Kuo; R Glanville; U Mayer; K Mann; R Deutzmann
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

10.  Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan.

Authors:  U Specks; U Mayer; R Nischt; T Spissinger; K Mann; R Timpl; J Engel; M L Chu
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.